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Abstract 
 Noninvasive hemodynamic monitoring has evolved steadily over the past few decades in 
response to healthcare providers' preference for less invasive monitoring methods for their patients.  
Invasive monitoring has its place in the critically ill patient population as witnessed in intensive care 
units throughout the country. Even in this environment, providers are opting less for the pulmonary 
artery catheter which has been the gold standard for invasive cardiac output monitoring in the past.  
Providers are now utilizing less invasive monitoring techniques which offer fewer potential 
complications to the patient while providing rapid access to critically important hemodynamic data.  
Examination of different noninvasive hemodynamic monitoring systems was completed in a literature 
review.  The findings indicate that clinical accuracy is variable from device to device, however as 
technology has progressed there has been general improvement in this area.  The appropriate clinical 
use for noninvasive hemodynamic monitoring is discussed based on evidence from the literature with a 
focus on the benefits and drawbacks that are associated with these systems as they specifically apply to 
the emergent trauma patient population.   
 
Introduction 
Noninvasive monitoring technology is uniquely poised to be of great benefit to the emergent 
trauma patient population.  Knowing these patients’ hemodynamic status is critical to guiding 
management of these patients appropriately in the early stages of injury and resuscitation.  Traditional 
monitoring of emergency trauma patients includes vital signs, urine output, and mental status.  One of 
the problems with treating trauma patients solely by traditional measurements is that by the time there 
is a change noticed, the patient has decompensated towards a state of shock.  As a patient’s 
hemodynamic status worsens, their response to treatment also worsens, thus making correction of the 
injury increasingly difficult.  Non-invasive monitoring techniques provide early recognition of changes in 
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hemodynamic status thus allowing for early treatment and improved responses to treatment.  This pre-
emptive treatment is critical for preventing hypoperfusion which can lead to irreversible organ damage, 
shock, and ultimately, death.  Understanding the risks and benefits of noninvasive hemodynamic 
monitoring will help the nurse anesthetist to determine the appropriate application of these 
technologies towards improving the outcomes of their patients.  This literature review examines the 
clinical research and application of various noninvasive hemodynamic techniques over the past 17 years.  
There have been multiple investigations of how noninvasive hemodynamic monitoring can be utilized in 
the hospital and emergency setting.  The purpose of this literature review is to examine the evolution 
and application of specific noninvasive hemodynamic techniques as they apply to the trauma and 
emergency patient population.  
 
Literature Review  
Early noninvasive monitoring techniques were investigated by researcher Dr. William C. 
Shoemaker and his research colleagues.  In 1999, they published a research article that examined the 
efficacy of early noninvasive hemodynamic monitoring after severe blunt trauma.  They used a newly 
developed thoracic bioimpedance device which continually measured cardiac output and provided a 
continuous real-time display of data.  The goal of the research was to determine if early identification 
and treatment of altered hemodynamic status via noninvasive monitoring in trauma patients would lead 
to more rapid and improved resuscitation (Velmahos, Wo, Demetriades, and Shoemaker, 1999). They 
noted that conventional monitoring which includes blood pressure, urine output, skin color, and mental 
status changes does not provide quantitative evaluation of cardiovascular function and these values may 
appear normal despite a significant hemodynamic deficit being present (Velmahos, Wo, Demetriades, 
and Shoemaker, 1999). The thoracic bioimpedance device was used in combination with a standard 
pulse oximeter, blood pressure cuff, a transcutaneous oxygen tension monitor, and a transcutaneous 
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carbon dioxide tension monitor.  The authors utilized thermodilution from pulmonary artery catheters 
to compare cardiac output values measured by the noninvasive monitor.  They found a correlation 
coefficient which the researchers determined to be acceptable in the clinical setting.  “The correlation 
coefficient for simultaneous pairs of samples of the two methods was r=0.91, r2=0.83. This is consistent 
with previous reports of critically ill patients predominantly in the ICU and was considered to be 
reasonably satisfactory from a clinical viewpoint” (Velmahos, Wo, Demetriades, and Shoemaker, 1999).  
The research results indicated that survivors and non-survivors had significantly different values as 
measured by the noninvasive monitoring which included cardiac index, oxygen saturation, and 
percutaneous oxygen and carbon dioxide tensions. They argued that these values could be used in the 
early resuscitative period to guide treatment as adequate resuscitation in the initial period after 
traumatic injury is critical and may determine patient outcome (Velmahos, Wo, Demetriades, and 
Shoemaker, 1999).  The authors concluded that the bioimpedance device correlated adequately with 
values measured simultaneously by pulmonary artery catheter thermodilution, however there was no 
clinically agreed level of acceptance from any other source that could confirm this adequate correlation 
between the two measurements; this was considered a limitation of the study (Velmahos, Wo, 
Demetriades, and Shoemaker, 1999).  Identifying early altered hemodynamic status in emergency 
trauma patients via easy to use noninvasive monitoring was an important and clinically useful research 
topic that other researchers would continue to build upon.   
Dr. Shoemaker was involved in another research project which utilized noninvasive monitoring 
as an early warning for the development of ARDS (acute respiratory distress syndrome) in trauma 
patients, published in 2000.  The goal was to identify appropriate hemodynamic monitoring early after 
injury.  Pulmonary artery catheterization, which is done in the critical care setting, provides metabolic 
oxygen delivery and consumption information, however this invasive monitoring is not readily available 
during the early resuscitation period in the emergency environment, whether that be the emergency 
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department or operating room (Tatevossian et al., 2000).  The researchers continuously monitored 
patients with transcutaneous oxygen and carbon dioxide tension measurements which were considered 
a substitute for invasive blood gas monitoring which only provides spot checks as opposed to continuous 
trending information.  Transcutaneous oxygen and carbon dioxide tensions were used to measure skin 
oxygenation and perfusion; the authors note that the skin is the first organ to manifest vasoconstriction 
and uneven blood flow from sympathetic stress stimulation thus providing a general picture of tissue 
perfusion function (Tatevossian et al., 2000).  A thoracic electrical bioimpedance device was also used to 
monitor cardiac output noninvasively.  The results of the study found certain trends that provided useful 
information; patients who did not develop ARDS had higher cardiac index and tissue perfusion levels 
than those who developed ARDS.  The survivors of ARDS had higher cardiac output and tissue perfusion 
values than those who died after ARDS.  This helped the authors to identify that monitoring and optimal 
treatment in the late stages after organ failure was ineffective due to severe oxygen debt already 
accumulated (Tatevossian et al., 2000).  The authors found that early recognition of changes in tissue 
perfusion and cardiac output could guide pre-emptive treatment and decrease the risk that the patient 
develops ARDS with the application of these noninvasive monitoring techniques.   
Shoemaker et al. (2006) published another article in the journal Military Medicine which 
examined how noninvasive monitoring for combat casualties could optimize patient outcomes.  
Shoemaker focused again on the importance of early monitoring and resuscitation in patients who had 
suffered traumatic injuries.  Recognition of altered hemodynamic status is crucial in this initial period 
after traumatic injury.  Delayed treatment has been shown to lead towards shock, organ failure, and 
death.  The authors noted that goal directed resuscitation therapy with invasive pulmonary artery 
catheterization did not improve outcomes as this monitoring was usually started greater than 24 hours 
after hospital admission or after onset of organ failure; however early preoperative hemodynamic 
optimization showed significant improvement in patient outcomes (in the setting of peripheral vascular 
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surgery, trauma, cardiogenic shock, and sepsis) (Shoemaker et al., 2006).  The researchers again used a 
thoracic bioimpedance device which was applied to patients shortly after arrival to the emergency 
department.  They cited previous studies which documented satisfactory correlation between these 
noninvasive monitoring devices and the gold standard invasive pulmonary artery catheter 
thermodilution measurement of cardiac output.  The authors did note the limitations of the 
bioimpedance device which is attached via thoracic electrode pads; these include faulty electrode 
placement, motion artifacts, patient restlessness, shivering, pulmonary edema, pleural effusion, valvular 
heart disease, dysrhythmias, and electrical leak from instruments using the same circuit (Shoemaker et 
al., 2006).  The study included 851 patients who survived and 149 patients who died during 
hospitalization with the mortality rate at 14.9%.  The authors generalized these large city trauma 
patients to similar combat casualties with the hypothesis that early noninvasive monitoring application 
on the battlefield would assist and guide first responders in their clinical judgment and treatment of 
these patients (Shoemaker et al., 2006).  They found that the survivors of the study had mean values of 
cardiac index and mean arterial pressure that were significantly higher than those of the non-survivors 
thus reflecting the improved status of survivors’ cardiac, pulmonary, and tissue perfusion functions 
(Shoemaker et al., 2006).  The identification of these values early on as opposed to waiting for late signs 
such as hypotension and conventional signs of shock and hypoperfusion allows for early treatment and 
improved patient outcomes.   
Dr. Shoemaker and his research team further examined  the feasibility of noninvasive 
hemodynamic monitoring for early recognition and identification of circulatory problems in patients 
who had suffered thoracic and abdominal penetrating trauma injuries.  The researchers again used a 
thoracic bioimpedance monitoring device (improved from previous models) which allowed for quick and 
easy application throughout the hospital environment (Asensio et al., 2006).  They also compared their 
noninvasive monitoring values to pulmonary artery thermodilution values after Swan-Ganz pulmonary 
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artery catheters were placed postoperatively.  The noninvasive cardiac output measurements were 
combined with pulse oximetry for estimation of arterial hemoglobin saturation which was meant to 
reflect pulmonary function; as well transcutaneous oxygen and carbon dioxide tensions which were 
utilized to reflect tissue perfusion and oxygenation.  The authors found that the noninvasive systems 
provided essential clinical data early on that was previously unattainable without the presence of an 
invasive monitor such as a pulmonary artery catheter.  Early circulatory abnormalities were identified in 
91% of these severe trauma patients (Asensio et al., 2006).  Regarding the correlation between 
noninvasive measurements and invasive measurements, the authors note that the differences in the 
absolute values of each simultaneous reading was offset by the value of continuous trending data being 
displayed by the noninvasive monitor (Asensio et al., 2006).   
In yet another study directed towards examining the feasibility and reliability of 
multicomponent noninvasive hemodynamic monitoring for trauma patients in the emergency 
department and operating room, Dr. Shoemaker and his research team monitored 993 trauma patients 
with major blunt or penetrating injuries shortly after admission to the emergency department. 
Hemodynamic values were attained noninvasively by a thoracic bioimpedance device which was applied 
shortly after arrival of the patient to the ED (Shoemaker et al., 2006).  The authors noted that 
application of the bioimpedance device simply entails applying leads, like an EKG, at the appropriate 
positions on the thorax.  Invasive hemodynamic values were attained via pulmonary artery 
catheterization and a radial artery catheter (Shoemaker et al., 2006).  The results demonstrated the 
limits of agreement between the invasive and noninvasive methods were 19.7% and the average 
difference between simultaneous noninvasive and invasive measurements was 9.7%.  The authors 
concluded that this data demonstrated satisfactory agreement between the two methods, however the 
cost of noninvasive monitoring was only 11% of the cost associated with invasive pulmonary artery 
catheterization and monitoring (Shoemaker et al., 2006).  The authors made an important observation 
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related to this research: in the early or incipient phase of trauma, shock frequently manifests as benign, 
however subsequently patients are found to deteriorate rapidly leading to critical illness, organ failure, 
and death (Shoemaker et al., 2006).  The application of these noninvasive monitoring systems in the 
early phase of trauma and shock development can provide essential hemodynamic information to guide 
resuscitation before patients begin to deteriorate thus greatly improving their outcome.  In addition, 
patients’ response to treatment in this early stage is far greater than the response to treatment once 
they become critically ill. 
There is a gap in some of the research on this topic after 2006, which may be due to limitations 
of noninvasive monitoring technology development.  There were various noninvasive monitoring 
devices in development during this time.  In 2010 a meta-analysis was published by the American 
Society of Anesthesiologists which examined the accuracy and precision of some minimally invasive 
monitoring devices which measured cardiac output during surgery and critical care.  They examined 4 
different monitoring methods including esophageal doppler, partial carbon dioxide rebreathing, thoracic 
bioimpedance, and pulse contour techniques (Peyton & Chong, 2010).  The authors conducted a 10-year 
review of studies with the goal of examining the level of agreement between noninvasive methods and 
bolus thermodilution via pulmonary artery catheterization, the latter being considered the gold 
standard for comparison.  Interestingly, these authors found that none of the four noninvasive methods 
met the criteria for acceptable agreement (determined in previous studies to be a percentage error of 
30% or less) (Peyton & Chong, 2010).  The weighted correlation coefficient was highest for thoracic 
electric bioimpedance at 0.79 and lowest with partial carbon dioxide rebreathing at 0.57.  The authors 
recognized a significant number of limitations to their meta-analysis; of the 47 studies reviewed, 34 
(72%) were done in cardiac surgery patients thus limiting the generalizability of the noninvasive devices 
beyond the cardiac patient to other patient populations. Cardiac patients may have heart dysrhythmias, 
valve disease, and other cardiovascular co-morbidities that limit the effectiveness of specific non-
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invasive monitors (Peyton & Chong, 2010).  Another limitation was the 10-year time span of their meta-
analysis.  Noninvasive monitoring was a rapidly developing field and they were unable to reflect 
improvements in newly available technologies.  Findings did indicate the four monitoring methods 
achieved limits of agreement between each other that were acceptable and the authors note that this is 
significant as the methods utilize very different physical and physiological principles (Peyton & Chong, 
2010).  The absolute values derived from these noninvasive devices have been shown to be of less value 
than the trending information they provide.  “In major surgery, reliable real-time tracking of the 
direction of changes in cardiac output is arguably more important than the ability of the monitor to 
deliver a highly accurate single measurement under stable conditions” (Peyton & Chong, 2010).   
A study published in 2012 examined how a lightweight trauma monitor could provide early 
indication of central hypovolemia and tissue acidosis.  The researchers used NIRS technology (near-
infrared spectroscopy) to determine muscle hemoglobin oxygen saturation and muscle hydrogen ion 
concentration.  This measurement of tissue pH is important as a clinical diagnostic value due to its 
significantly increased sensitivity to the development of shock as opposed to measures of arterial and 
venous pH (Soller et al., 2012).  Noninvasive sensors were placed on the subject’s forearms which 
collected reflectance spectra data from deep within the forearm muscle every 20 seconds.  The 
researchers placed subjects in a lower body negative pressure environment to simulate a model of pre-
shock hemorrhage.  The results demonstrated that muscle oxygenation decreased in proportion to 
reductions in central blood volume with a strong positive relationship.  The researchers also noted that 
muscle oxygenation was one of the earliest indicators of progressive central hypovolemia as compared 
with delayed alterations in standard vital signs.  There was also a small yet significant reduction in 
muscle pH once muscle oxygenation levels reached a critically low level (Soller et al., 2012).  The authors 
concluded that their research provided evidence that NIRS monitoring was capable of reflecting early 
signs of blood loss which can indicate that splanchnic organs may be experiencing inadequate oxygen 
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delivery (Soller et al., 2012).  This noninvasive measurement of muscle oxygenation and pH were shown 
to be excellent indicators of early stage compensated shock.  In addition, the NIRS monitoring system 
was designed to be lightweight, small, and easy to use (Soller et al., 2012). 
The Nexfin noninvasive monitoring device, developed by Edwards Life Sciences, uses an 
inflatable finger cuff with a small box attached to the wrist which is used to indirectly measure finger 
arterial blood pressure.  This value is then placed in an algorithm which converts the finger arterial 
pressure into beat-to-beat measurements of brachial blood pressures.  In addition, the Nexfin device 
provides cardiac output values based on pulse contour analysis (Chen et al., 2012).  This device was 
investigated in a study published in 2012 which assessed its ability to detect hypotension and 
hypertension earlier than the standard blood pressure cuff in patients undergoing general anesthesia.  
The sample included 25 patients referred for abdominal or orthopedic surgery.  The researchers found 
that the median percentage error of the Nexfin cuff compared to the standard blood pressure cuff was 
40.3% (Chen et al., 2012).  The authors concluded that a concordance of only 81.3% between standard 
blood pressure readings and Nexfin readings necessitated further research to determine the accuracy of 
the Nexfin device (Chen et al., 2012).  The real value of the Nexfin may be in observing trends of blood 
pressure which can assist in early detection of blood pressure changes and lead to timely intervention 
thus improving patient outcomes.   
The NICOM (Noninvasive Cardiac Output Monitor) is another device based on thoracic 
bioimpedance technology which was developed by Cheetah Medical Inc. This device was utilized in a 
research study examining how noninvasive cardiac output measurements in the emergency department 
are associated with trauma activation, patient injury severity, and length of stay (Dunham et al., 2012).  
The NICOM sensors were applied to the torso after patients arrived to the emergency department at a 
Level I trauma center and monitoring was continued for 60 to 90 minutes.  Cardiac output 
measurements were achieved easily and quickly once the sensors were in place.  270 patients were 
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included in the study with NICOM cardiac outputs available from 242, or 89.6%.  The researchers found 
that the NICOM cardiac output values were significantly useful as they displayed appropriate variations 
with injury severity, co-morbidity, and survival in acutely injured trauma patients. The cardiac outputs 
were shown to be significantly higher in hypotensive patients who were not hemorrhaging as opposed 
to hypotensive patients that were hemorrhaging (Dunham et al., 2012).  This was used to assist the 
clinician in choosing the appropriate treatment (I.e. fluids vs. vasopressors).  Patient length of stay was 
shown to be increased in non-survivors (compared to non-survivors without NICOM who succumbed 
faster), but decreased in survivors (compared to survivors without NICOM that experienced increased 
complications requiring lengthier treatment) (Dunham et al., 2012).  The NICOM device was found to be 
capable of providing objective, clinically valid, relevant, and discriminate cardiac output data in this 
adult acute trauma patient population (Dunham et al., 2012).   
The Nexfin monitor was the subject of another research study published in 2013 which 
examined the validation of the device against continuous pulse contour and intermittent 
transpulmonary thermodilution via pulmonary artery catheter.  Continuous pulse contour analysis was 
done via the PiCCO system (a less invasive system that requires a central line and arterial line, however 
still uses noninvasive pulse contour analysis to measure cardiac output) (Ameloot et al., 2013).  The 
study included 47 critically ill patients admitted to the medical, surgical, and burn intensive care units at 
a major medical center.  Results showed moderate to good correlation coefficients with the pulmonary 
artery catheter thermodilution method (0.68) and PiCCO method (0.71).  The percentage errors were 
considered too high however to be considered clinically acceptable; the authors cited other research 
studies that came to similar conclusions when investigating the validity of the Nexfin device (Ameloot et 
al., 2013).  The Nexfin device was found to be most accurate in patients with a high cardiac output and 
low systemic vascular resistance and least accurate in patients with the opposite characteristics such as 
in trauma and sepsis patients.  Additionally, the Nexfin produced unreliable data in hypothermic 
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patients (Ameloot et al., 2013).  The authors concluded that the Nexfin device may be an appropriate 
initial hemodynamic assessment that could act as a bridge to placement of more invasive/accurate 
monitoring systems.  The value of the device may be found in tracking changes in cardiac output rather 
than relying on absolute values to determine cardiac output (Ameloot et al., 2013).   
There was increased research on the various noninvasive hemodynamic monitoring systems as 
technologies continued to be modified and improved over time.  The NICOM (Cheetah Medical) was 
investigated as being a feasible option for hemodynamic monitoring of air-evacuated casualties in a 
2013 study.  The study examined 16 patients who were air evacuated by the French army health service 
and placed on the NICOM monitor (Dubost et al., 2013).  The researchers found that the monitor was 
feasible for transport during long flights without any signal loss or interferences noted and monitoring 
allowed for fine-tuning of fluid management in these unstable trauma patients (Dubost al., 2013).   
Partial end-tidal carbon dioxide is another noninvasive monitoring method that has been 
utilized to determine cardiac output in patients.  Dunham et al. (2013) investigated the statistical 
relationship between cardiac output and end-tidal carbon dioxide while at the same time correlating 
cardiac output levels with patient injury severity levels, blood pressure, heart rate, blood loss, 
transfusions, abnormal pupils, cardiac arrest, and death (Dunham et al., 2013).  They reviewed 73 
emergently intubated patient's records who had NICOM cardiac output monitors in place.  They found 
that low end-tidal carbon dioxide levels were associated with low cardiac output and patients with 
major blood loss had a significant reduction in both of these values.  Patients who were hypotensive but 
did not have blood loss displayed normal cardiac output and end-tidal levels implying that cardiac 
output and end-tidal carbon dioxide values may be helpful in making clinical decisions when managing 
hypotensive trauma patients (Dunham et al., 2013).  The authors found that preserved cardiac output 
and end-tidal carbon dioxide levels in the hypotensive trauma patient implied the absence of blood loss.  
The authors do note that  low levels do not necessarily indicate that there is hemorrhage as there can be 
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other causes of low cardiac output and end-tidal carbon dioxide (cardiac contusions, tamponade, 
tension pneumothorax, or heart failure) (Dunham et al., 2013).  
Masimo is another company that has developed noninvasive hemodynamic monitoring devices; 
their Radical 7 system has been approved to measure hemoglobin noninvasively via a 
spectrophotometric self-calibrating sensor with light-emitting diodes and a photodetector which 
analyzes the patient via a finger probe (Moore, et al, 2013). Hemoglobin is commonly used to assist in 
identifying hemorrhage in trauma patients; trending these levels continuously would assist the clinician 
in identifying and treating blood loss.  The system was investigated in a research study published in 2013 
in order to evaluate the accuracy of the sensor hemoglobin levels to lab drawn hemoglobin levels.  The 
patient sample was 525 trauma admissions for which 418 had readable outputs from the finger probe 
(Moore et al, 2013).  The correlation between the sensor and lab drawn hemoglobin levels was found to 
be poor and in addition the device failed to detect hemoglobin values in 34% of the readouts.  The 
authors note previous studies on this device have shown good clinical correlation in euvolemic patients; 
however accuracy was poor in patients with trauma and suspected blood loss (Moore et al., 2013).  The 
Radical-7 was concluded to have limited clinical application in patients with hemorrhagic shock/trauma.   
The Nexfin device was the subject of another study in 2014 which investigated whether the 
device could help diagnose patients suffering from suspected heart failure, sepsis, and stroke (Nowak et 
al., 2014).  The researchers enrolled 514 subjects in the study with 4 excluded due to suspected finger 
cuff failure of the Nexfin unit.  The data retrieved from the subjects showed that cardiac index and 
stroke volume index, as measured by the Nexfin, were highest in sepsis, followed by stroke, and lowest 
in acute heart failure (Nowak et al., 2014).  The authors concluded that the data from the Nexfin could 
play a potential role in helping to diagnose and individualize treatment for this population of patients in 
the future (Nowak et al, 2014.)   
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The Nexfin has also been studied for its ability to measure pulse pressure variation and stroke 
volume variation for the monitoring of intraoperative fluid shifts.  A 2014 research study observed 54 
patient's response to a provoked fluid shift (patients were placed in Trendelenberg position).  The Nexfin 
was able to reflect alterations in the pulse pressure variations and stroke volume variation while mean 
arterial pressure and cardiac index were not sensitive enough to reflect any changes (Stens et al, 2014).  
The Nexfin derived values of pulse pressure variation and stroke volume variation were of additional 
value to static indices for clinical assessment of fluid shifts in patients under anesthesia (Stens et al., 
2014).  The authors do note the limitation of the Nexfin's accuracy, "Nexfin cardiac values have proven 
to be unreliable in studies with critically ill patients, since they included patients with potentially 
compounding factors due to abnormal vascular tone, peripheral hypoperfusion due to septic shock, or 
cardiac stunning" (Stens et al., 2014). Trauma patients generally fall into the category of critically ill, 
which would limit the usefulness of the Nexfin device for this purpose.   
The Radical-7 by Masimo was investigated in another research study designed to assess the 
accuracy of continuous noninvasive hemoglobin monitoring for the prediction of blood transfusion in 
trauma patients (Galvagno et al., 2014).  The study enrolled 1191 patients of which 711 had available 
hemoglobin data obtained from the Radical-7 device.  Subjects had the finger probe sensor applied upon 
admission to a trauma resuscitation unit with the primary outcome of interest being the administration 
of at least one unit of packed red blood cells within the first 12 hours (Galvango et al., 2014).  Results 
showed that hemoglobin monitoring by the Radical-7 alone did not enhance predictive models showing 
the need for blood transfusion, however when combined with continuous vital signs, and adjusted for 
age and sex, the predictive value had good accuracy (Galvango et al., 2014).  The researchers concluded 
that, in the trauma population, the cost of implementing such a device could not be justified until 
development of devices with increased accuracy (Galvango et al., 2014). 
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Joseph et al. (2015) examined the Radical-7 by Masimo, this time in the setting of trauma 
patients.  The researcher's goal was to evaluate the efficacy and accuracy of a spot check noninvasive 
hemoglobin measuring device compared to invasive laboratory measurements in trauma patients 
(Joseph et al., 2015).  The study sample included 525 patients with a successful readability rate of 86% 
thus reducing the sample to 450.  They found that the difference between mean hemoglobin values of 
the noninvasive and invasive methods was only 0.3 g/do (plus or minus 3.6 g/do).  The noninvasive spot 
check measurements were shown to have a strong correlation with the invasive measurements with 
76% accuracy and 95.4 % accuracy (Joseph et al., 2015).  The failure of the device to capture readings in 
75 (14%) patients and the inconsistency of the device to collect measurements may be due to several 
factors such as low perfusion states, motion artifact, and disconnection of the sensor.  In conclusion, the 
authors state that the inability of the device to recognize readings in trauma patients with life-
threatening hemorrhage is a failure of the device and as a result, further evaluations need to be done 
before implementation of the device into clinical practice (Joseph et al., 2015).   
The NICOM, a thoracic bioimpedance noninvasive cardiac output monitor, was the subject of 
investigation by researchers Berlin et al. in a study published in 2017 which was designed to test the 
researcher's hypothesis that the NICOM has acceptable agreement with bolus thermodilution from a 
pulmonary artery catheter in a wide range cardiac outputs.  The researchers used a porcine model (8 
Yorkshire swine weighing between 48-55 kg) of hemorrhagic shock and resuscitation as their model 
(Berlin et al., 2017).  The data they collected and analyzed suggested an acceptable agreement between 
the invasive and noninvasive methods with a strong correlation between simultaneous measurements.  
The authors demonstrated a 97% concordance of values as plotted on a four-quadrant x/y axis. They 
made a distinction of cardiac output measurements that had also been made by other researchers: 
"Given the inherent error of all cardiac output monitoring (whether noninvasive or invasive), trending 
may be more important than the absolute values" (Berlin et al., 2016).  The generalizability of the 
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porcine model to the human model is a limitation of the study although the authors claim this 
substitution is supported by previous use of porcine models to evaluate cardiac output monitors.  The 
model used in this study claimed similar clinical features to human hemorrhage and resuscitation (Berlin 
et al., 2016).   
A recent development in the field of noninvasive hemodynamic monitors is the Cipher Ox CRI 
(compensatory reserve index) tablet (tablet is their monitor platform, not an oral medication).  The CRI 
is a new hemodynamic parameter which trends changes in a patient's intravascular volume relative to 
the individual patient's response to hypovolemia (Moulton et al., 2017).  This index was just approved 
for use by the FDA in December of 2016.  The CRI is a cardiovascular status indicator which is derived 
from a mathematical equation that equates the proportion of additional volume loss a patient can 
tolerate before hemodynamic decompensation occurs.  CRI values range from 1 to 0 with 1 representing 
100% and 0 representing 0%.  The 1 corresponds to supine normovolemia while 0 implies imminent 
decompensation and circulatory collapse.  The CRI decreases as a patient experiences volume loss, 
whether from bleeding or dehydration and CRI increases as the patient receives volume resuscitation. 
Patient tolerance to volume loss is different from individual to individual due to various factors such as 
ambient temperature, pain, medications, comorbidities, and innate physiologic capacity to compensate 
for volume loss (Moulton et al., 2017).   The Cipher Ox tablet, which measures CRI via a finger probe, 
was evaluated in a research study that showed the CRI did have the ability to accurately, continuously, 
and noninvasively trend changes in intravascular volume for individual patients who experience 
moderate volume loss and replacement.  Patients who had limited innate tolerance for volume loss had 
lower CRI estimates after blood loss than subjects who had a higher tolerance thus demonstrating the 
device's ability to individualize the CRI measurement effectively (Moulton et al., 2017). The clinical value 
of this device is observed as CRI values decrease over time which is indicative of rapid progression to 
hemodynamic decompensation due to central volume loss.  The CRI has been shown to be far more 
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sensitive to volume loss than traditional monitoring methods when patients are asymptomatic (early 
phase of acute injury) and has also been shown to have increased accuracy in anticipating cardiovascular 
collapse when compared to derived parameters such as pulse pressure index and pulse pressure 
variation (Moulton et al., 2017).  The limitation of this study is its application to trauma patients who 
have experienced major volume loss.  The authors simulated blood loss by removing 333ml per subject 
rather than a percentage of blood loss per person.  Other noninvasive hemodynamic monitoring 
systems that utilize finger sensor technology have proven to be accurate in normovolemic patients but 
inaccurate in patients that have undergone major volume loss (Moulton et al., 2017).  The Cipher Ox 
tablet needs to be evaluated in the setting of the emergency trauma patient before introduction of this 
device into clinical practice with these types of patients. 
In a recent study published in July of 2017, Masimo's Radical-7 probe was again evaluated for 
hemoglobin monitoring specifically in trauma patients.  The subjects of this study were 113 trauma 
patients who already had hemoglobin levels less than 8gm/dL.  Forty-three patients were excluded due 
to hemoglobin levels higher than 8gm/dL leaving 70 patients to be included in the study (Gamal et al., 
2017).  The researchers found low bias and strong correlation between noninvasive hemoglobin values 
and lab drawn values with a Pearson correlation coefficient of 0.872.  The mean Radical-7 value for all 
samples was 6.7 gm/dL while the mean lab drawn value was 6.5 gm/dL (Gamal et al., 2017).  Patients 
were measured at various stages in patient management including the resuscitation, preoperative, and 
intraoperative phases.  The authors note that although all of their subjects were experiencing active 
bleeding, none of the subjects were in shock which may be an important limitation as the Masimo 
device has been shown to be more accurate in patients with adequate perfusion (Gamal et al., 2017).  
They conclude that the Radical-7 showed accurate precision in both absolute values and trend values 
compare to lab drawn measurements in trauma patients (Gamal et al, 2017). 
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The use of noninvasive hemodynamic monitoring in the clinical setting has been steadily 
increasing as evidence shows that hemodynamic instability and hypoperfusion are major contributing 
factors for organ failure and death.  Invasive hemodynamic techniques have important limitations, 
especially towards treatment of trauma patients; this is evidenced by the time and personnel needed for 
pulmonary artery catheter placement.  There are dangerous complications that can accompany this 
procedure as well such as central infection, blood vessel damage, severe bleeding, pneumothorax, 
damage to cardiac valve structures, and dangerous arrhythmias (Kuster, Exadaktylos, and Schnuriger, 
2015).  Noninvasive techniques offer a solution by allowing for easy, quick, and early application in the 
clinical and emergency setting during the initial evaluation of the patient.  Noninvasive monitoring 
interferes less with clinical management than invasive methods and provides a continuous real-time 
display of measurements which permits early recognition of altered hemodynamic status compared to 
traditional monitoring methods in the early stages of trauma patient management (Kuster, Exadaktylos, 
and Schnuriger, 2015).  The accuracy of various noninvasive techniques has been the subject of 
numerous research studies as seen in this literature review.  Overall, the NICOM device has been shown 
to have the best accuracy in trauma patients with the Nexfin device providing the least accurate 
information, however each method has unique advantages and disadvantages which need to be 
acknowledged by the clinician.  There is evidence pointing in different directions for the overall accuracy 
of specific devices.  The research suggests that the best approach may be to utilize noninvasive 
monitoring as an adjunct to other patient information and data when making treatment decisions. 
 
Discussion 
The ability of the anesthesia provider to understand and effectively use these monitoring 
systems for their patients is essential.  The value of these devices lies in providing early hemodynamic 
data that would otherwise only be attainable via placement of invasive monitors.  Application of these 
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devices should be done by qualified pre-hospital emergency services or by emergency department 
providers once the patient has arrived at the hospital.  This critical window of time in emergency trauma 
patients is invaluable at directing early resuscitation efforts and fluid replacement.  Patients in the early 
stages of shock will not necessarily display changes in basic parameters such as vital signs, mental status, 
urine output, skin color, and temperature which makes early diagnosis and treatment of shock related 
to trauma extremely difficult.  Early application of noninvasive hemodynamic monitoring can provide 
early warnings of impending shock and thus guide appropriate preemptive treatment which would assist 
in preventing the rapid deterioration that occurs in the later stages of shock.  For those patients that 
require immediate life-saving surgery, the early resuscitation administered based on derived 
noninvasive hemodynamic data would greatly assist the anesthesia provider preparing to place the 
patient under anesthesia.  These patients should have increased hemodynamic stability in the face of 
traumatic shock and the anesthesia provider will have a better idea of how their status is trending with 
regards to cardiac output and/or blood loss.   
The NICOM device, a thoracic bioimpedance device which is applied with 4 leads on the thorax 
similar to ECG leads, has been shown to have the greatest accuracy for cardiac output compared to 
other devices although it has limitations as well.  Funk, Moretti, and Tong (2009) explain that thoracic 
bioimpedance is affected by tissue fluid volume as well as volume changes of pulmonary and venous 
blood that are induced by respiration.  As a result, this interference must be filtered out from the 
desired changes in volumetric blood flow of the aorta.  Alterations in the position or contact of the 
electrodes will thus affect these measurements (Funk, Morreti, and Tong, 2009).  Cardiac irregularities 
including dysrhythmias, valve disease, and right heart failure can also contribute to limiting the 
effectiveness of these devices.  Newer devices have overcome some of these challenges by increasing 
signal processing as well as improving signal filtering, ECG triggering, arrhythmia detection, and 
respiratory filtering (Funk, Morreti, and Tong, 2009).  Application of a thoracic bioimpedance monitoring 
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system would ideally be in the field or ambulance while on route to a level 1 trauma center, however 
placement in the emergency department would also be effective in identifying early changes in 
hemodynamic status.  This monitor may become of less value once the patient is moved into the 
operating room and surgery commences as the intraoperative environment is less conducive to accurate 
measurements of cardiac output due to interference by noise from electrocautery, mechanical 
ventilation and surgical manipulation (Funk, Morreti, and Tong, 2009).  The goal is for early resuscitation 
to be administered prior to the patient entering the operating room.  In doing so, this will have 
prevented the patient from rapidly decompensating while additionally buying time for anesthesia 
personnel who are able to place more invasive lines once surgery has begun.   
The noninvasive finger-cuff devices include the Nexfin device, which has been re-developed into 
the ClearSight system by Edwards Lifesciences.  This technology utilizes a volume clamp method; this 
involves clamping the artery to a constant volume by dynamically providing equal pressure on either 
side of the arterial wall. The volume is measured by a photo-plethysmograph built into the cuff.  The 
counter pressure is applied by an inflatable bladder inside the cuff and is adjusted 1000 times per 
second to keep the arterial volume constant.  Edwards utilizes a mathematical real-time calculation 
referred to as Physiocal which determines the proper arterial ‘unloaded’ volume, i.e. the volume 
without a pressure gradient across the arterial wall.  Per Edwards, the Physiocal method can analyze the 
curvature and sharpness of the plethysmogram during short episodes of constant pressure levels. 
Physiocal then automatically and periodically recalibrates the system to allow for accurate tracking of 
physiologic changes (Edwards Lifesciences, 2018).  Like thoracic bioimpedance, this device can be 
applied in the pre-hospital setting by emergency services or in the emergency department and provide 
hemodynamic information including cardiac index, stroke volume, stroke volume variation, systemic 
vascular resistance and continuous blood pressure.  One of the drawbacks associated with previous 
Nexfin technology has been the loss of accuracy in patients that are already hemodynamically 
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compromised and have low peripheral vascular resistance.  Trauma patients are likely to fall into this 
category thus limiting the effectiveness of these devices in this patient population.  Edwards reports 
improved accuracy with their most recent incarnation of Nexfin technology, the ClearSight system.  One 
of the positive aspects of this device is that it can be brought into the OR with the patient and not suffer 
from interference caused by electrocautery.  The device is also not likely to interfere with surgical prep 
or procedure as it stays on the patient’s finger and wrist.  Patient limiting factors that apply to this 
device include peripheral vascular disease, Raynaud’s disease, or any other condition that affects 
circulation to the extremities.   
The minimally invasive technologies that utilize pulse contour analysis were not included in the 
literature review as they require some invasive lines to function (usually an arterial line).  These devices, 
which include the PiCCO, LiDCO, and FloTrac, are worth mentioning as they offer the same 
hemodynamic information provided by the noninvasive monitors however with improved accuracy as 
they are calibrated to an invasive line.  These systems have drawbacks of their own though as pulse 
contour cardiac output measurements rely on a good quality of arterial trace; as a result, overdamping 
or underdamping can lead to unreliable cardiac output measurements (Critchley, 2011).   
A noninvasive hemodynamic monitoring method that was not identified in the literature review 
is the esophageal doppler which utilizes ultrasound technology to measure cardiac output.  The 
advantages of using Doppler technology include the ability to remain in position for days to weeks, its 
proximity to the aorta, and the size of the probe which is approximately the size of a nasogastric tube 
and can be positioned easily (Funk, Morreti, and Tong, 2009).  Doppler technology relies on physiological 
assumptions such as the aorta being cylindrical shaped and predetermines the patient’s aortic radius 
based on age, sex, weight, and height from which it calculates stroke volume based on pulsatile aortic 
blood flow (Funk, Morreti, and Tong, 2009).  Esophageal doppler only measures descending aortic blood 
flow (70% of cardiac output), excluding blood flow to the aortic arch vessels, and as a result a correction 
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factor of 30%is introduced into the calculation of cardiac output.  While this correction factor has been 
shown to be accurate in healthy individuals, the correction constant may not be suitable for patients in 
shock whose hemodynamic status may be undergoing drastic changes (Funk, Morreti, and Tong, 2009).  
Another limitation of this technology is that correct and accurate measurements are operator 
dependent and there is a relatively (compared to other noninvasive monitoring devices) steep learning 
curve.  Probe position is critical to obtain accurate flow measurements and as a result additional training 
is necessary for staff to utilize this technology correctly.  While esophageal doppler cardiac output 
measurements have been shown to have the highest accuracy when used correctly, this technology may 
not be ideal for trauma patients who are unstable as there may be spurious measurements recorded in 
the chaotic environment which usually surrounds an incoming trauma patient to the hospital.  This 
technology may be of more use once the patient has been brought into the OR and anesthesia induction 
has commenced.  Trans-esophageal echocardiogram ultrasound is a similar option for the patient in the 
operating room; this technology is also operator dependent as the provider must be trained to correctly 
perform a TEE to obtain accurate cardiac output values.   
Masimo’s noninvasive systems do not offer cardiac output measurements, however they do 
provide total hemoglobin, methemoglobin, carboxyhemoglobin, oxygen saturation, oxygen content, and 
pleth index from their Rainbow SET monitoring platform.  The literature is variable on the accuracy of 
Masimo’s devices.  The most recent article on Masimo’s noninvasive monitoring system published in 
2017 shows a good correlation between lab drawn hemoglobin values and hemoglobin values derived 
from Masimo’s finger probe.  One of the issues that has been found to limit the accuracy of these 
devices (which was also a limitation with the Nexfin finger cuff technology) is patients who are in active 
decompensating shock.  Studies have shown that the accuracy of these devices was reduced significantly 
in patients with severely compromised hemodynamic statuses.  On the other hand, these devices are 
excellent for trending hemoglobin levels which may assist the provider in making the decision to 
NONINVASIVE HEMODYNAMIC MONITORING 23 
transfuse blood products.  Literature suggests not relying solely on these devices to make a transfusion 
decision; its optimal use would be in assisting the provider to make a judgment in conjunction with 
other patient diagnostic information (vital signs, labs, urine output, surgical blood loss).   
Each of these various noninvasive hemodynamic monitoring systems has been studied and used 
by clinicians with the goal of optimizing patient outcomes.  The anesthesia provider who decides to 
utilize noninvasive monitoring for their patient needs to understand the appropriate application of these 
devices as well as the limitations that exist with each of these systems.  The trauma patient would 
benefit most from noninvasive monitoring in the early stages of injury and shock where appropriate 
resuscitation would prevent acute decompensation.  The patient’s odds of a positive outcome following 
trauma surgery greatly increase if the acute decompensation of shock can be prevented or delayed.  The 
provider should also recognize that the technology of these devices is always advancing.  It is essential 
for the provider to continue to read the literature and studies on these devices as they progress and 
decide for themselves the appropriate use and value as pertains to their individual patient.   
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